Javascript must be enabled to continue!
Acid Mucopolysaccharides As Cofactor in Formation of Platelet-clumping Substance
View through CrossRef
Abstract
Incubation at 37°C for 30 min or the addition of CaCl2 (5 mM) generated platelet-clumping activity in citrated plasma and EDTA plasma previously acidified to pH 5.5 and in which heparin was added to give a concentration of 0.5 mg/ml. Similar treatment could not produce platelet-clumping activity in saline or denatured plasma that had been heated to 56°C. Heparin, chondroitin sulfate B, or heparan sulfate produced platelet-clumping activity in BaSO4-adsorbed serum over a given pH range. The effective pH range for each compound was; heparin 0.5 mg/ml, pH 5.16 ± 0.09 to 6.31 ± 0.14; chondroitin sulfate B 0.5 mg/ml, pH 5.62 ± 0.09 to 6.88 ± 0.06; 2 mg/ml, pH 5.17 ± 0.16 to 7.18 ± 0.16. The effect of heparan sulfate in generating platelet-clumping activity was estimated only qualitatively at pH 6.0 and proved to be positive. Chondroitin sulfate A, chondroitin sulfate C, and hyaluronic acid failed to yield platelet-clumping activity in BaSO4-adsorbed plasma. The minimal concentrations of heparin and chondroitin sulfate B necessary to induce platelet-clumping activity in the BaSO4-adsorbed serum were 0.5 mg/ml and 0.1 mg/ml, respectively.
American Society of Hematology
Title: Acid Mucopolysaccharides As Cofactor in Formation of Platelet-clumping Substance
Description:
Abstract
Incubation at 37°C for 30 min or the addition of CaCl2 (5 mM) generated platelet-clumping activity in citrated plasma and EDTA plasma previously acidified to pH 5.
5 and in which heparin was added to give a concentration of 0.
5 mg/ml.
Similar treatment could not produce platelet-clumping activity in saline or denatured plasma that had been heated to 56°C.
Heparin, chondroitin sulfate B, or heparan sulfate produced platelet-clumping activity in BaSO4-adsorbed serum over a given pH range.
The effective pH range for each compound was; heparin 0.
5 mg/ml, pH 5.
16 ± 0.
09 to 6.
31 ± 0.
14; chondroitin sulfate B 0.
5 mg/ml, pH 5.
62 ± 0.
09 to 6.
88 ± 0.
06; 2 mg/ml, pH 5.
17 ± 0.
16 to 7.
18 ± 0.
16.
The effect of heparan sulfate in generating platelet-clumping activity was estimated only qualitatively at pH 6.
0 and proved to be positive.
Chondroitin sulfate A, chondroitin sulfate C, and hyaluronic acid failed to yield platelet-clumping activity in BaSO4-adsorbed plasma.
The minimal concentrations of heparin and chondroitin sulfate B necessary to induce platelet-clumping activity in the BaSO4-adsorbed serum were 0.
5 mg/ml and 0.
1 mg/ml, respectively.
Related Results
Appearance of Platelet-Clumping Substance after Acidification of Plasma
Appearance of Platelet-Clumping Substance after Acidification of Plasma
Abstract
1. The pH values of heparinized plasma from ten normal rabbits were from 7.53 to 7.80. The average pH and standard error was 7.69 ± 0.03. These plasmas did ...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Plasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect of aspi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
AbstractPlasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect...
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Abstract
Background: Primary immune Thrombocytopenia (ITP) is an acquired autoimmune hemorrhagic disorder characterized ...
The Role of Personality and Stress in the Development of Substance Use Disorder among Substance Use Disorder Patients in Kaduna State, Nigeria
The Role of Personality and Stress in the Development of Substance Use Disorder among Substance Use Disorder Patients in Kaduna State, Nigeria
This study investigated the role of personality and stress in the development of substance use disorder among substance use disorder patients in Kaduna State. A cross sectional des...
Platelet Antagonists
Platelet Antagonists
Platelet antagonists play an important role in both primary and secondary prevention of atherothrombotic events. Despite their proven benefit, individual response (and protection) ...

